Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of 29th of July, we are planning to work on 21 projects, including:

Reimbursement

  1. Starting reimbursement analysis for MRI technology in Germany
  2. Working on the reimbursement analysis and strategy for a number of in-vitro diagnostic tests in the obstetrics and gynecology field in Belgium, Bulgaria, the Czech Republic, France, Germany, Italy, Norway, Romania, and Switzerland
  3. Starting reimbursement analysis for a neurostimulator in the cardiology field in England, France, Germany and Italy
  4. Working on coding guides for physicians for technology in the cardiology field in England, Germany and Switzerland
  5. Working on reimbursement analysis and strategy for in-vitro diagnostic test in the diabetes field in Belgium and Italy
  6. Working on reimbursement analysis for medical technology in the ICU settings in Austria, Belgium, England, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden and Switzerland
  7. Starting reimbursement analysis project for four cardiology and peripheral vascular technologies in Italy and Poland
  8. Finalizing reimbursement analysis for medical technology in the urology field in England, France, Germany, Italy, and Spain
  9. Working on reimbursement analysis for medical technology in the cardiology field in Belgium, the Czech Republic, Denmark, Finland, Luxembourg, the Netherlands, Norway, and Sweden
  10. Kicking off a project including reimbursement analysis, qualitative interviews and literature review to develop value propositions for 10 medical technologies in the obstetrics and gynecology field in France, Germany, Italy, and Spain
  11. Kicking off a policy analysis project, including qualitative interviews in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 

HEOR

  1. Finalizing search strategies and inclusion criteria, and starting work on individual chapters of a value dossier for a urinary technology
  2. Working on adaptations of the health economic model for in-vitro diagnostic test in infectious diseases area in France and Spain
  3. Finalizing the global value dossier for a genetic test
  4. Implementing feedback from the client on the policy paper for diabetes technology
  5. Performing additional search and meta-analysis of the data to inform the possibility of a health economic analysis as an extension of the value dossier project for a technology in a critical care field
  6. Working on the development of the health economic model for a technology to treat venous disease in Germany
  7. Starting development of a European value dossier for a wound care product
  8. Working on Evidence Gap Analysis for an imaging technology in a cardiology space
  9. Working on the development of the health economic model for technology in the breast cancer space in the UK
  10. Finalizing project on the collection of unit cost items for resource use in the cardiology field in Germany, Italy, the Netherlands and Sweden

Let us know if you need any market access or HEOR support for your medical technology in Europe.